Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+

Journal of Cell Science

Volumn 119, Issue 18, 2006, Pages 3799-3810

  Huston, Elaine ^a   Gall, Irene ^a   Houslay, Thomas M ^b   Houslay, Miles D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ca2+; Cyclic AMP; Golgi; PDE4A; Phosphatidic acid; Trafficking

Indexed keywords

ASPARTIC ACID; CALCIUM ION; CYCLIC AMP; LEUCINE; PHENYLALANINE; PHOSPHATIDIC ACID; PHOSPHODIESTERASE IV; PHOSPHOLIPASE D;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE MUTATION; GOLGI COMPLEX; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN TARGETING;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; THAPSIGARGIN; TRANS-GOLGI NETWORK;

EID: 33750322320     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.03106     Document Type: Article

References (54)

1. Baillie, G. S. and Houslay, M. D. (2005). Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin. Cell Biol. 17, 129-134.
2. Baillie, G. S., Huston, E., Scotland, G., Hodgkin, M., Gall, I., Peden, A. H., MacKenzie, C., Houslay, E. S., Currie, R., Pettitt, T. R. et al. (2002). TAPAS-1, a novel microdomain within the unique N-terminal region ofthe PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid. J. Biol. Chem. 277, 28298-28309.
3. Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J. and Houslay, M. D. (2003). beta-Arrestin-mediated PDF4 cAMP phospbodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc. Natl. Acad Sci. USA 100, 940-945.
4. Baillie, G. S., Scott, J. D. and Houslay, M. D. (2005). Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett. 579, 3264-3270.
5. Beard, M. B., O'Connell, J. C., Bolger, G. B. and Houslay, M. D. (1999). The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains. FEBS Lett. 460, 173-177.
6. Bolger, G. B., McCahill, A., Huston, E., Cheung, Y. F., McSorley, T., Baillie, G. S. and Houslay, M. D. (2003). The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins. J. Biol. Chem. 278, 49230-49238.
7. Brown, F. D., Thompson, N., Saqib, K. M., Clark, J. M., Powner, D., Thompson, N. T., Solari, R. and Wakelam, M. J. (1998). Phospholipase D1 localises to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation. Curr Biol. 8, 835-838.
8. Colley, W. C., Sung, T. C., Roll, R., Jenco, J., Hammond, S. M., Altshuller, Y., Bar-Sagi, D., Morris, A. J. and Frohman, M. A. (1997). Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7, 191-201.
9. Cooper, D. M. (2003). Regulation and organization of adenylyl cyclases and cAMP. Biochem. J. 375, 517-529.
10. Davis, R. L., Takayasu, H., Eberwine, M. and Myres, J. (1989). Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene. Proc. Natl. Acad. Sci. USA 86, 3604-3608.
11. Delon, C., Manifava, M., Wood, E., Thompson, D., Krugmann, S., Pyne, S. and Ktistakis, N. T. (2004). Sphingosine kinase 1 is an intracellular effector of phosphatidic acid. J. Biol. Chem. 279, 44763-44774.
12. Dodge, K. L., Khouangsathiene, S., Kapiloff, M. S., Mouton, R., Hill, E. V., Houslay, M. D., Langeberg, L. K. and Scott, J. D. (2001). mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 20, 1921-1930.
13. Dumaz, N. and Marais, R. (2005). Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272, 3491-3504.
14. Exton, J. H. (2002). Regulation of phospholipase D. FEBS Lett. 531, 58-61.
15. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and Chen, J. (2001). Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942-1945.
16. Freyberg, Z., Bourgoin, S. and Shields, D. (2002). Phospholipase D2 is localized to the rims of the Golgi apparatus in mammalian cells. Mol. Biol. Cell 13, 3930-3942.
17. Freyberg, Z., Siddhanta, A. and Shields, D. (2003). "Slip, sliding away": phospholipase D and the Golgi apparatus. Trends Cell Biol. 13, 540-546.
18. Ghosh, S., Strum, J. C., Sciorra, V. A., Daniel, L. and Bell, R. M. (1996). Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells. J. Biol. Chem. 271, 8472-8480.
19. Gleeson, F. A., Lock, J. G., Luke, M. R. and Stow, J. L. (2004). Domains of the TGN: coats, tethers and G proteins. Traffic 5, 315-326.
20. Goodwin, J. S., Drake, K. R., Rogers, C., Wright, L., Lippincott-Schwartz, J., Philips, M. R. and Kenworthy, A. K. (2005). Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J. Cell Biol. 170, 261-272.
21. Grange, M., Sette C., Cuomo, M., Conti, M., Lagarde, M., Prigent, A. F. and Nemoz, G. (2000). The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphaddic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J. Biol. Chem. 275, 33379-33387.
22. Hammond, S. M., Altshuller, Y. M., Sung, T. C., Rudge, S. A., Rose, K., Engebrecht, J., Morris, A. J. and Frohman, M. A. (1995). Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270, 29640-29643.
23. Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q., Cook, S., Nozawa, Y., Prestwich, G. D., Frohman, M. A. and Morris, A. J. (1997). Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J. Biol. Chem. 272, 3860-3868.
24. Hancock, J. F., Paterson, H. and Marshall, C. J. (1990). A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63, 133-139.
25. Houslay, M. D. and Kolch, W. (2000). Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58, 659-668.
26. Houslay, M. D. and Adams, D. R. (2003). PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370, 1-119.
27. Houslay, M. D., Schafer, P. and Zhang, K. Y. (2005). Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov. Today 10, 1503-1519.
28. Huston, E., Pooley, L., Julien, P., Scotland, G., McPhee, L., Sullivan, M., Bolger, G. and Houslay, M. D. (1996). The human cyclic AMP-specific phosphodiesterase PDE46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J. Biol. Chem. 271, 31334-31344.
29. Huston, E., Beard, M., McCallum, F., Pyne, N. J., Vandenabeele, P., Scotland, G. and Houslay, M. D. (2000). The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. J. Biol. Chem. 275, 28063-28074.
30. Karathanassis, D., Stahelin, R. V., Bravo, J., Perisic, O., Pacold, C. M., Cho, W. and Williams, R. L. (2002). Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J. 21, 5057-5069.
31. Manifava, M., Thuring, J. W., Lim, Z. Y., Packman, L., Holmes, A. B. and Ktistakis, N. T. (2001). Differential binding of traffic-related proteins to phosphatidic acid- or phosphatidylinositol (4,5)- bisphosphate-coupled affinity reagents. J. Biol. Chem. 276, 8987-8994.
32. McPhee, I., Yarwood, S. J., Scotland, G., Huston, E., Beard, M. B., Ross, A. H. Houslay, E. S. and Houslay, M. D. (1999). Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition. J. Biol. Chem. 274, 11796-11810.
33. McPhee, I., Cochran, S. and Houslay, M. D. (2001). The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms. Cell. Signal. 13, 911-918.
34. Meier, K. E., Gibbs, T. C., Knoepp, S. M. and Ella, K. M. (1999). Expression of phospholipase D isoforms in mammalian cells. Biochim. Biophys. Acta 1439, 199-213.
35. Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S. et al. (2005). DISCI and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310, 1187-1191.
36. Ouyang, Y. S., Tu, Y., Barker, S. A. and Yang, F. (2003). Regulators of G-protein signaling (RGS) 4, insertion into model membranes and inhibition of activity by phosphatidic acid. J. Biol. Chem. 278, 11115-11122.
37. Pediani, J. D., Colston, J. F., Caldwell, D., Milligan, G., Daly, C. J. and McGrath, J. C. (2005). Beta-arrestin-dependent spontaneous alpha1a-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments. Mol. Pharmacol. 67, 992-1004.
38. Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D. et al. (2002). Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298, 834-836.
39. Pooley, L., Shakur, Y., Rena, G. and Houslay, M. D. (1997). Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines. Biochem. J. 321, 177-185.
40. Rizzo, M. A., Shome, K., Watkins, S. C. and Romero, G. (2000). The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J. Biol. Chem. 275, 23911-23918.
41. Sciorra, V. A., Hammond, S. M. and Morris, A. J. (2001). Potent direct inhibition of mammalian phospholipase D isoenzymes by calphostin-c. Biochemistry 40, 2640-2646.
42. Scotland, G. and Houslay, M. D. (1995). Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVA1) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase. Biochem. J. 308, 673-691.
43. Shakur, Y., Pryde, J. G. and Houslay, M. D. (1993). Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292, 677-686.
44. Shakur, Y., Wilson, M., Pooley, L., Lobban, M., Griffiths, S. L., Campbell, A. M., Beattie, J., Daly, C. and Houslay, M. D. (1995). Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem. J. 306, 801-809.
45. Smith, K. J., Scotland, G., Beattie, J., Trayer, I. P. and Houslay, M. D. (1996). Determination of the structure of the N-terminal splice region of the cyclic AMP-specific phosphodiesterase RD1 (RNPDE4A1) by 1H NMR and identification of the membrane association domain using chimeric constructs. J. Biol. Chem. 271, 16703-16711.
46. Steed, P. M., Clark, K. L., Boyar, W. C. and Lasala, D. J. (1998). Characterization of human PLD2 and the analysis of PLD isoform splice variants. FASEB J. 12, 1309-1317.
47. Tasken, K. and Aandahl, E. M. (2004). Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84, 137-167.
48. Tasken, K. A., Collas, P., Kemmner, W. A., Witezak, O., Conti, M. and Tasken, K. (2001). Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J. Biol. Chem. 276, 21999-22002.
49. Verde, I., Pahlke, G., Salanova, M., Zhang, G., Wang, S., Coletti, D., Onuffer, J., Jin, S. L. and Conti, M. (2001). Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J. Biol. Chem 276, 11189-11198.
50. Wong, W. and Scott, J. D. (2004). AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5, 959-970.
51. Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L. and Tarlinton, D. M. (2005). Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22, 9-18.
52. Yarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D. and Bolger, G. B. (1999). The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J. Biol. Chem. 274, 14909-14917.
53. Zaccolo, M., Magalhaes, P. and Pozzan, T. (2002). Compartmentalisation of cAMP and Ca(2+) signals. Curr. Opin. Cell Biol. 14, 160-166.
54. Zhang, F. L. and Casey, P. J. (1996). Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65, 241-269.